Access over 1 million publication pages and stay up to date with what's happening in your field.
Value Added Abstracts
Ahmed N. Ghanem
Hypothesis: The transurethral resection of the prostate (TURP) syndrome is defined as severe vascular hypotension reaction that complicates endoscopic.. Read More »Original Articles
Vaishali Agme-Ghodke, Rupali N
The bioactive components of leaves extract of Centella Asiatica have been evaluated by using HRLC-Ms techniques. This technique is easy, rapid and con.. Read More »Research Article
Nwafor Ifeanyi E and Ogbu Ogbo
Background: Cytomegalovirus has been identified as the major cause of morbidity and mortality among neonates. It commonly occurs in immunocompro.. Read More »Research Article
Rutahoile WM, David NM, Ang
Background: In settings where new drugs for pulmonary arterial hypertension (PAH) are not possible due to lack of availability and cost; PDE-5 inhibit.. Read More »Research Article
Rongying Li, Hsu Chao, Kerry W
A reduction in low density lipoprotein (LDL) cholesterol or an increase in high density lipoprotein (HDL) cholesterol can reduce the risk of developme.. Read More »Original Articles
Sagar Jadav, P. V. Habbu, Rash
The objective of research work was to evaluate and perform stability study of prepared and developed S ennoside A and B capsule. The Sennoside .. Read More »Research Article
Osman H
The precise quantitative evaluation of hydrogenous material; such as water and oil; is problematic because of their high scatter contribution which bl.. Read More »Research Article
Ankalu Dasa*, Nandhakumar Sath
The challenge up-front in formulating an efficient oral dosage form for a proton pump inhibitor like pantoprazole is delivering the acid liable drug .. Read More »Research Article
Mahabubul Islam Majumder, Tare
Catheter-Associated Urinary Tract Infection (CAUTI) is a common health care associated infection worldwide and is result of wide spread use of urinary.. Read More »Special Issue Article
Yoshio Aizawa and Hiroshi A
A first-generation protease inhibitor (PI) against HCV non-structural 3/4A serine protease was approved worldwide at the end of 2011. We are now facin.. Read More »